Results 191 to 200 of about 230,380 (304)

Gut–Brain Axis Modulation by Short‐Chain Fatty Acids Exerts Disease‐Modifying Effects in a Murine Model of Drug‐Resistant Epilepsy

open access: yesAnnals of Neurology, EarlyView.
Objective Drug‐resistant epilepsy (DRE) remains a clinical challenge, as therapies modifying disease trajectory are lacking. Increasing evidence implicates gut microbiota dysbiosis in epilepsy pathophysiology, with short‐chain fatty acids (SCFAs) emerging as key microbial metabolites with neuroprotective and anti‐inflammatory properties.
Akash A. Bera   +16 more
wiley   +1 more source

Cohesin acetylation and ATPase activity control cohesion and loop architecture through distinct mechanisms. [PDF]

open access: yesProc Natl Acad Sci U S A
Costantino L   +7 more
europepmc   +1 more source

Tunable Regional Targeting of Self‐Assembling Peptide Nanomaterials in Acute Myocardial Infarction

open access: yesAdvanced NanoBiomed Research, EarlyView.
In a rat model of acute myocardial infarction, intravascular delivery of peptide nanofibers with a collagen‐targeting peptide bound to the infarct vasculature while globular peptide nanoparticles penetrated into the infarct area. This study demonstrated that size, shape, and surface chemistry of nanomaterials control the delivery location within the ...
Alexander Chen   +14 more
wiley   +1 more source

An intricate functional relationship between NuA4 and Sfp1 regulates ribosome biogenesis in response to nutrient availability. [PDF]

open access: yesJ Biol Chem
Xu K   +8 more
europepmc   +1 more source

HDAC8 impairs tight junctions in allergic rhinitis through Smad7 deacetylation. [PDF]

open access: yesFront Immunol
Chang HH   +6 more
europepmc   +1 more source

Acetylation.

open access: yesExperimental Biology and Medicine, 1927
B. Harrow, F. W. Power, C. P. Sherwin
openaire   +1 more source

Late‐Stage Functionalization of Peptides on the Solid Phase

open access: yesAngewandte Chemie International Edition, EarlyView.
Peptide modifications are essential to control pharmacodynamic and pharmacokinetic properties of peptide drugs. Consequently, strategies that allow for efficient and rapid incorporation of non‐canonical modifications into peptides in parallel formats are highly sought after.
Marius Werner   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy